{"count": 4, "results": [{"_id": "34256673", "pmid": 34256673, "title": "Lentiform fork sign in a uremic patient after inadvertent exposure to metformin.", "journal": "Clin Toxicol (Phila)", "authors": ["Chang YA", "Tarng DC", "Yang CY"], "date": "2022-03-01T00:00:00Z", "doi": "10.1080/15563650.2021.1953519", "meta_date_publication": "2022 Mar", "meta_volume": "60", "meta_issue": "3", "meta_pages": "406-407", "score": 50271.844, "text_hl": "Lentiform fork sign in a @<m>DISEASE_Hemolytic_Uremic_Syndrome</m> @DISEASE_MESH:D006463 @@@uremic@@@ @SPECIES_9606 @@@patient@@@ after inadvertent exposure to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Chang YA, Tarng DC, Yang CY. Lentiform fork sign in a uremic patient after inadvertent exposure to metformin. Clin Toxicol (Phila). 2022 Mar;60(3):406-407. PMID: 34256673", "BibTeX": "@article{34256673, title={Lentiform fork sign in a uremic patient after inadvertent exposure to metformin.}, author={Chang YA and Tarng DC and Yang CY}, journal={Clin Toxicol (Phila)}, volume={60}, number={3}, pages={406-407}}"}}, {"_id": "33785333", "pmid": 33785333, "title": "Concerted outcome of metformin and low dose of radiation in modulation of cisplatin induced uremic encephalopathy via renal and neural preservation.", "journal": "Life Sci", "authors": ["Hasan HF", "Rashed LA", "El Bakary NM"], "date": "2021-07-01T00:00:00Z", "doi": "10.1016/j.lfs.2021.119429", "meta_date_publication": "2021 Jul 1", "meta_volume": "276", "meta_issue": "", "meta_pages": "119429", "score": 50258.676, "text_hl": "Concerted outcome of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and low dose of radiation in modulation of @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@cisplatin@@@ induced @<m>DISEASE_Hemolytic_Uremic_Syndrome</m> @DISEASE_MESH:D006463 @@@uremic encephalopathy@@@ via renal and neural preservation.", "citations": {"NLM": "Hasan HF, Rashed LA, El Bakary NM. Concerted outcome of metformin and low dose of radiation in modulation of cisplatin induced uremic encephalopathy via renal and neural preservation. Life Sci. 2021 Jul 1;276():119429. PMID: 33785333", "BibTeX": "@article{33785333, title={Concerted outcome of metformin and low dose of radiation in modulation of cisplatin induced uremic encephalopathy via renal and neural preservation.}, author={Hasan HF and Rashed LA and El Bakary NM}, journal={Life Sci}, volume={276}, pages={119429}}"}}, {"_id": "34868569", "pmid": 34868569, "pmcid": "PMC8602957", "title": "Case Report: A Case of Encephalopathy Presenting the Lentiform Fork Sign on MRI in a Diabetic Dialysis Patient", "journal": "F1000Res", "authors": ["Ishizaki Y", "Nishizono R", "Kikuchi M", "Inagaki H", "Sato Y", "Fujimoto S"], "date": "2020-08-11T00:00:00Z", "doi": "10.12688/f1000research.25597.3", "meta_date_publication": "2020", "meta_volume": "9", "meta_issue": "", "meta_pages": "969", "score": 50249.223, "text_hl": "@DISEASE_Brain_Diseases @DISEASE_MESH:D001927 @@@ME@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-associated @DISEASE_Brain_Diseases @DISEASE_MESH:D001927 @@@encephalopathy@@@; @<m>DISEASE_Hemolytic_Uremic_Syndrome</m> @DISEASE_MESH:D006463 @@@DUS@@@, @<m>DISEASE_Hemolytic_Uremic_Syndrome</m> @DISEASE_MESH:D006463 @@@diabetic uremic syndrome@@@.", "citations": {"NLM": "Ishizaki Y, Nishizono R, Kikuchi M, Inagaki H, Sato Y, Fujimoto S. Case Report: A Case of Encephalopathy Presenting the Lentiform Fork Sign on MRI in a Diabetic Dialysis Patient F1000Res. 2020;9():969. PMID: 34868569", "BibTeX": "@article{34868569, title={Case Report: A Case of Encephalopathy Presenting the Lentiform Fork Sign on MRI in a Diabetic Dialysis Patient}, author={Ishizaki Y and Nishizono R and Kikuchi M and Inagaki H and Sato Y and Fujimoto S}, journal={F1000Res}, volume={9}, pages={969}}"}}, {"_id": "28483424", "pmid": 28483424, "title": "The Effect of Uremic Solutes on the Organic Cation Transporter 2.", "journal": "J Pharm Sci", "authors": ["Cheung KWK", "Hsueh CH", "Zhao P", "Meyer TW", "Zhang L", "Huang SM", "Giacomini KM"], "date": "2017-09-01T00:00:00Z", "doi": "10.1016/j.xphs.2017.04.076", "meta_date_publication": "2017 Sep", "meta_volume": "106", "meta_issue": "9", "meta_pages": "2551-2557", "score": 50044.66, "text_hl": "We first screened 72 @<m>DISEASE_Hemolytic_Uremic_Syndrome</m> @DISEASE_MESH:D006463 @@@uremic solutes@@@ as inhibitors of [14C]-labeled @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ uptake by @GENE_SLC22A2 @GENE_6582 @@@OCT2@@@. ", "citations": {"NLM": "Cheung KWK, Hsueh CH, Zhao P, Meyer TW, Zhang L, Huang SM, Giacomini KM. The Effect of Uremic Solutes on the Organic Cation Transporter 2. J Pharm Sci. 2017 Sep;106(9):2551-2557. PMID: 28483424", "BibTeX": "@article{28483424, title={The Effect of Uremic Solutes on the Organic Cation Transporter 2.}, author={Cheung KWK and Hsueh CH and Zhao P and Meyer TW and Zhang L and Huang SM and Giacomini KM}, journal={J Pharm Sci}, volume={106}, number={9}, pages={2551-2557}}"}}]}